Liver Fibrosis Scans Coming Soon to CGH
Velacur is an ultrasound imaging tool that physicians use to measure liver stiffness, attenuation and VDFF which are the leading indicators of fatty liver disease. The Velacur procedure is painless, non-invasive and can be performed in 10 minutes, with results that can be reviewed immediately.
About Fatty Liver Disease:
Fatty liver disease is the fastest-growing segment of chronic liver disease. It is estimated that more than one in three adults suffer from Metabolic Dysfunction-Associated Steatotic Liver Disease aka. MASLD (previously non-alcoholic fatty liver disease, NAFLD). With early detection and intervention fatty liver disease can be halted or even reversed.
Fatty liver disease is caused by an excess amount of fat in the liver. Usually a small amount of excess fat isn’t problematic, but for about 20% of those with fatty liver, the condition gradually progresses and leads to inflammation in the liver. Inflammation in the liver can cause scar tissue build up (a process called fibrosis). When scar tissue extensively replaces healthy tissue and impairs liver function, cirrhosis occurs which dramatically increases the chances of liver failure or cancer.
Fatty liver disease often has no noticeable symptoms, some subtle signs include fatigue, nausea, and abdominal pain. If you have type 2 diabetes, obesity, hypertension, or other metabolic diseases, you may be at higher risk for fatty liver disease. With early detection and intervention, fatty liver disease can be halted or even reversed.